Annual accounts
Micro Entity accounts
31/07/2026Filing deadline
Made up to 31/10/2024Due 31/07/2026
- Next accounts made up to
- 31/10/2025
- Last accounts made up to
- 31/10/2024
NJ BIOPHARMA CONSULTING LIMITED
Active- 10409217Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- 66 Kenilworth Road, Sale, Greater Manchester M33 5DB
- Classification (SIC)
- Other professional scientific and technical activities n.e.c. (74.90/9 - SIC 2007)
- Accounts type
- Micro Entity
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 29/07/2026View PDF (4 pages)
Micro company accounts made up to 2025-10-31
- 28/10/2025View PDF (4 pages)
Confirmation statement made on 2025-10-18 with updates
- 21/10/2025View PDF (2 pages)
Change of details for Dr Neil Ian Johnson as a person with significant control on 2025-10-06
- 20/10/2025View PDF (3 pages)
Statement of capital following an allotment of shares on 2025-10-06
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
56 days overdue
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 18/10/2026
- Last statement dated
- 31/10/2024
Financial performance
The latest figures NJ BIOPHARMA CONSULTING LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
£221.44K2025
3.43%vs 20242024: £214.09K
Total Assets
£278.28K2025
-2.17%vs 20242024: £284.45K
Total Liabilities
£56.84K2025
-19.22%vs 20242024: £70.36K
Employees
42025
0vs 20242024: 4
Of the 3 measures with an earlier filing to compare against, 1 rose and 2 fell. Total liabilities moved furthest, down 19.22% on 2024. See the full financial analysis for NJ BIOPHARMA CONSULTING LIMITED.
The full financial record
Four ways through NJ BIOPHARMA CONSULTING LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · -2.6% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved4 chartsCharts by indicator4 filed indicators plotted year by year, 2021–2025.Plot the figuresNothing estimatedRatios from the filed figures2 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 5 yearsEvery figure by yearAll 5 measures Okredo tracks across 5 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 4 | 0 |
| 2024 | 4 | 0 |
| 2023 | 4 | +2 |
| 2022 | 2 | 0 |
| 2021 | 2 | – |
Reported employee count increased from 2 in 2021 to 4 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
1Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 04/10/2016–Present | 0 |
Persons with significant control
5Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 04/10/2016–06/08/2023 | 0 | |
| 04/10/2016–Present | 0 | |
| 04/11/2016–Present | 1 | |
| 04/11/2016–06/08/2023 | 1 | |
| 20/12/2024–Present | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 35 Since 04/10/2016
- Last 12 months
- 4 -1 vs the year before
- Most recent filing
- 29/07/2026 1 month ago
What changed in the last year
- Accounts filedLatest 29/07/2026
- Confirmation statementLatest 28/10/2025
- Officer changesLatest 21/10/2025
- Share capitalLatest 20/10/2025
Filing timeline
- 29/07/2026View PDF (4 pages)
Micro company accounts made up to 2025-10-31
- 28/10/2025View PDF (4 pages)
Confirmation statement made on 2025-10-18 with updates
- 21/10/2025View PDF (2 pages)
Change of details for Dr Neil Ian Johnson as a person with significant control on 2025-10-06
- 20/10/2025View PDF (3 pages)
Statement of capital following an allotment of shares on 2025-10-06
- 17/01/2025View PDF (6 pages)
Micro company accounts made up to 2024-10-31
- 24/12/2024View PDF (2 pages)
Notification of Neil Ian Johnson as a person with significant control on 2024-12-20
- 23/12/2024View PDF (2 pages)
Withdrawal of a person with significant control statement on 2024-12-23
- 23/12/2024View PDF (3 pages)
Statement of capital following an allotment of shares on 2024-12-20
- 18/10/2024View PDF (4 pages)
Confirmation statement made on 2024-10-18 with updates
- 23/04/2024View PDF (6 pages)
Micro company accounts made up to 2023-10-31
- 18/10/2023View PDF (5 pages)
Confirmation statement made on 2023-10-04 with updates
- 10/08/2023View PDF (2 pages)
Notification of a person with significant control statement
Showing 12 of 35 filings
See when the next accounts and confirmation statement are due
Similar companies
1,052 UK companies are similar to NJ BIOPHARMA CONSULTING LIMITED, sharing the same company status (Active), the same industry sector and activity group (Other professional scientific and technical activities n.e.c.) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
PURPLE PLANET ASTROLOGY LTD
Active80-83 Long Lane, London EC1A 9ET
- Activity
- Other professional scientific and technical activities n.e.c.
- Company no.
- 11453873
- Incorporated
- 09/07/2018
- Employees
- 3
THE INTERNET IFA LIMITED
Active23 Westminster Terrace, Glasgow G3 7RU
- Activity
- Other professional scientific and technical activities n.e.c.
- Company no.
- SC189077
- Incorporated
- 07/09/1998
- Employees
- 3
REALSERVICE LTD
ActivePrama House, 267 Banbury Road, Oxford OX2 7HT
- Activity
- Other professional scientific and technical activities n.e.c.
- Company no.
- 03680246
- Incorporated
- 08/12/1998
- Employees
- 4
NEON SQUARED STUDIOS LIMITED
ActiveShed - Workspace 2, 8 Lee Street, London E8 4DY
- Activity
- Other specialist photography
- Company no.
- 09661310
- Incorporated
- 29/06/2015
- Employees
- 4
J D AD ART LIMITED
ActiveOakleigh Cottage, Parklands Road, Bristol BS3 2JW
- Activity
- specialised design activities
- Company no.
- 01416569
- Incorporated
- 23/02/1979
- Employees
- 3
About NJ BIOPHARMA CONSULTING LIMITED
A short description of the company, written from its Companies House record.
NJ BIOPHARMA CONSULTING LIMITED is a private limited company registered in the United Kingdom, based in 66 Kenilworth Road, Sale, Greater Manchester M33 5DB. Companies House classifies its business as Other professional scientific and technical activities n.e.c.. It has been on the register for 9 years 11 months.
The register currently records it as active. Its 2025 accounts report net assets of £221.44K and 4 employees. Its accounts are past the filing deadline shown on the registry record.
NJ BIOPHARMA CONSULTING LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does NJ BIOPHARMA CONSULTING LIMITED do?
Companies House records NJ BIOPHARMA CONSULTING LIMITED under one registered business activity: Other professional scientific and technical activities n.e.c. (74.90/9 - SIC 2007).
Is NJ BIOPHARMA CONSULTING LIMITED still active?
NJ BIOPHARMA CONSULTING LIMITED is recorded as active on the Companies House register, and has been on it since 04/10/2016.
What are NJ BIOPHARMA CONSULTING LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2025 and report net assets of £221.44K, total assets of £278.28K and total liabilities of £56.84K.
When did NJ BIOPHARMA CONSULTING LIMITED last file with Companies House?
The most recent document on the record is dated 29/07/2026: Micro company accounts made up to 2025-10-31, 1 month ago.
When are NJ BIOPHARMA CONSULTING LIMITED's next filings due?
On the current registry record, accounts are due by 31/07/2026, which has passed.
Who runs NJ BIOPHARMA CONSULTING LIMITED?
Companies House lists 1 officer and 5 people with significant control (3 current).